Do low-grade and low-volume prostate cancers bear the hallmarks of malignancy? - ScienceDirect
Human prostate cancer xenograft. (A) Change of tumor volume during... | Download Scientific Diagram
September 15, 2014 - What Constitutes High-Volume/Extensive Disease? - The ASCO Post
Cancers | Free Full-Text | Tumor Location and a Tumor Volume over 2.8 cc Predict the Prognosis for Japanese Localized Prostate Cancer
Triplet or Doublet Therapy in Metastatic Hormone-sensitive Prostate Cancer Patients: A Systematic Review and Network Meta-analysis - European Urology Focus
The small molecule WNT/β-catenin inhibitor CWP232291 blocks the growth of castration-resistant prostate cancer by activating the endoplasmic reticulum stress pathway | Journal of Experimental & Clinical Cancer Research | Full Text
Is tumour volume an independent predictor of outcome after radical prostatectomy for high-risk prostate cancer? | Prostate Cancer and Prostatic Diseases
Kaiser Permanente researchers develop new prostate cancer risk calculator – NCAL Research Spotlight
Guidelines for radiotherapy of prostate cancer (2020 edition) - Li - 2021 - Precision Radiation Oncology - Wiley Online Library
ASCO GU 2020: Targeted Therapy in the Context of Low Volume Metastatic Prostate Cancer
Tumor clone dynamics in lethal prostate cancer | Science Translational Medicine
Describing Prostate Cancer Dynamics: Second Look at PSA- Doubling Time and PSA-Specific Growth Rate | IntechOpen
Relationship between prostate cancer volume and prostate volume for... | Download Scientific Diagram
![Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram](https://www.researchgate.net/profile/Thomas-Lam-3/publication/344701128/figure/tbl1/AS:947382543978497@1602885008589/Definition-of-high-and-low-volume-and-risk-in-CHAARTED-54-56-and-LATITIDE-57-based.png "Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram")
Definition of high and low volume, and risk in CHAARTED [54-56] and... | Download Scientific Diagram
PSMA PET for the Assessment of Metastatic Hormone-Sensitive Prostate Cancer Volume of Disease | Journal of Nuclear Medicine
Evaluation of Neutrophil, Lymphocyte, Platelet, Mean Platelet Volume, Neutrophil-Lymphocyte Ratio, and Platelet-Lymphocyte Ratio in Prostate Cancer Patients Treated with Radiotherapy | Medical Science and Discovery
Visual estimation of the tumor volume in prostate cancer: a useful means for predicting biochemical-free survival after radical prostatectomy? | Prostate Cancer and Prostatic Diseases
Prostate Cancer, An Issue of Urologic Clinics (Volume 44-4) (The Clinics: Surgery, Volume 44-4): 9780323549059: Medicine & Health Science Books @ Amazon.com
The Prostate: Vol 83, No 1
EAU 2018: Variation in Prevalence of High and Low Volume Metastatic Prostate Cancer from the Original Comparison in the STAMPEDE Trial
2.6 Solutions | lineaRmodels
The roles of MRI-based prostate volume and associated zone-adjusted prostate-specific antigen concentrations in predicting prostate cancer and high-risk prostate cancer | PLOS ONE
EAU 2018: Variation in Prevalence of High and Low Volume Metastatic Prostate Cancer from the Original Comparison in the STAMPEDE Trial
Quantification of Metastatic Prostate Cancer Whole-Body Tumor Burden with 18F-FDG PET Parameters and Associations with Overall Survival After First-Line Abiraterone or Enzalutamide: A Single-Center Retrospective Cohort Study | Journal of Nuclear Medicine
